Laval university, Department of Medicine, Institut des nutraceutiques et des aliments fonctionnels.
Québec, Quebec, G1V 0A6, Canada
NCT Number: NCT01444625
As flavanols have antioxidants, anti-inflammatory and anti-DNA damaging effects and may increase microcirculation in skin, the purpose of the study is to investigate the chronic effect of flavanol-rich chocolate as an effective strategy to protect against the harmful effect of ultraviolet (UV) radiation.
Looking for future studies?
Notify Me20 year–65 year
Female
Interventional
Phase 2
Québec, Quebec, G1V 0A6, Canada
Recent data suggested that chronic ingestion of high flavanols cocoa might be a promising agent for dietary photo protection against UV light. Moreover, flavanols-rich cocoa intake has been shown to increase microcirculation in human skin.
Healthy volunteers accepted: Yes
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
High-flavanol chocolate, 12 weeks.
Other names: Experimental dark chocolate
Flavanol-free chocolate, 12 weeks
Other names: Placebo flavanol-free chocolate
Time frame: within the first 12 weeks of chocolate intake and 3 weeks later after end of chocolate consumption
Time frame: within the first 12 weeks of chocolate intake and 3 weeks later after end of chocolate consumption
Time frame: within the first 12 weeks of chocolate intake and 3 weeks later after end of chocolate consumption
Time frame: within the first 12 weeks of chocolate intake and 3 weeks later after end of chocolate consumption
Laval University
Other
Flavanols and Skin Photo Protection: a Double Blind Clinical Trial
Acronym: CHOCOPO
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT03006185
Actinic Keratosis, Keratosis
View Trial DetailsNCT02224937
Solar Skin Damage
Herlev, Denmark
View Trial Details